Clinical Trial Update: Treatment of Acute Myeloid Leukemia (AML) in Adults 50 to 70 Years, Study of Two Anthracyclines and the Interest of Maintenance Treatment With Interleukin 2 [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating two anthracyclines and maintenance interleukin-2 for adults with acute myeloid leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Daunorubicin (daunorubicin)
• Doxorubicin (doxorubicin)
• Interleukin-2 (interleukin-2)

Snippet

Sponsor: Acute Leukemia French Association | Conditions: Acute Myeloid Leukemia | Phase 3 | Status: COMPLETED